🚀 VC round data is live in beta, check it out!
AmorePacific Valuation Multiples
Discover revenue and EBITDA valuation multiples for AmorePacific and similar public comparables like Bausch + Lomb, Colgate-Palmolive (India), Yakult Honsha, Fielmann Group and more.
AmorePacific Overview
About AmorePacific
AmorePacific Corp is a Korea-based company engaged in the manufacture and sale of beauty, personal care, and household products. The company operates through two main divisions: the Cosmetics Business Division, which includes premium and luxury brands such as Sulwhasoo, Hera, Laneige, IOPE, Aestura, and COSRX; and the Daily Beauty (DB) Business Division, which focuses on household and personal care brands including Ryeo, Mise-en-scene, and Happy Bath. It generates the majority of its revenue from the Cosmetics business division.
Founded
2006
HQ
Employees
4.7K
Website
Sectors
Financials (LTM)
EV
$5B
AmorePacific Financials
AmorePacific reported last 12-month revenue of $3B and EBITDA of $424M.
In the same LTM period, AmorePacific generated $2B in gross profit, $424M in EBITDA, and $186M in net income.
Revenue (LTM)
AmorePacific P&L
In the most recent fiscal year, AmorePacific reported revenue of $3B and EBITDA of $433M.
AmorePacific expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 72% | XXX | 72% | XXX | XXX | XXX |
| EBITDA | $424M | XXX | $433M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $186M | XXX | $163M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 6% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
AmorePacific Stock Performance
AmorePacific has current market cap of $6B, and enterprise value of $5B.
Market Cap Evolution
AmorePacific's stock price is $80.88.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $6B | 0.0% | XXX | XXX | XXX | $2.36 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAmorePacific Valuation Multiples
AmorePacific trades at 1.7x EV/Revenue multiple, and 12.0x EV/EBITDA.
EV / Revenue (LTM)
AmorePacific Financial Valuation Multiples
As of April 20, 2026, AmorePacific has market cap of $6B and EV of $5B.
Equity research analysts estimate AmorePacific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
AmorePacific has a P/E ratio of 30.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 12.0x | XXX | 11.8x | XXX | XXX | XXX |
| EV/EBIT | 20.0x | XXX | 22.2x | XXX | XXX | XXX |
| EV/Gross Profit | 2.4x | XXX | 2.4x | XXX | XXX | XXX |
| P/E | 30.0x | XXX | 34.3x | XXX | XXX | XXX |
| EV/FCF | 16.8x | XXX | 15.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified AmorePacific Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
AmorePacific Margins & Growth Rates
AmorePacific's revenue in the last 12 month grew by 7%.
AmorePacific's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.4M for the same period.
AmorePacific's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
AmorePacific's rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
AmorePacific Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | 10% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 32% | XXX | 36% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 64% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
AmorePacific Public Comps
See public comps and valuation multiples for other Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AmorePacific | XXX | XXX | XXX | XXX | XXX | XXX |
| Bausch + Lomb | XXX | XXX | XXX | XXX | XXX | XXX |
| Colgate-Palmolive (India) | XXX | XXX | XXX | XXX | XXX | XXX |
| Yakult Honsha | XXX | XXX | XXX | XXX | XXX | XXX |
| Fielmann Group | XXX | XXX | XXX | XXX | XXX | XXX |
| GSK India | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AmorePacific M&A Activity
AmorePacific acquired XXX companies to date.
Last acquisition by AmorePacific was on XXXXXXXX, XXXXX. AmorePacific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by AmorePacific
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAmorePacific Investment Activity
AmorePacific invested in XXX companies to date.
AmorePacific made its latest investment on XXXXXXXX, XXXXX. AmorePacific invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by AmorePacific
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout AmorePacific
| When was AmorePacific founded? | AmorePacific was founded in 2006. |
| Where is AmorePacific headquartered? | AmorePacific is headquartered in South Korea. |
| How many employees does AmorePacific have? | As of today, AmorePacific has over 4K employees. |
| Who is the CEO of AmorePacific? | AmorePacific's CEO is Kyung-Bae Seo. |
| Is AmorePacific publicly listed? | Yes, AmorePacific is a public company listed on Korea Exchange. |
| What is the stock symbol of AmorePacific? | AmorePacific trades under 090430 ticker. |
| When did AmorePacific go public? | AmorePacific went public in 2006. |
| Who are competitors of AmorePacific? | AmorePacific main competitors are Bausch + Lomb, Colgate-Palmolive (India), Yakult Honsha, Fielmann Group. |
| What is the current market cap of AmorePacific? | AmorePacific's current market cap is $6B. |
| What is the current revenue of AmorePacific? | AmorePacific's last 12 months revenue is $3B. |
| What is the current revenue growth of AmorePacific? | AmorePacific revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of AmorePacific? | Current revenue multiple of AmorePacific is 1.7x. |
| Is AmorePacific profitable? | Yes, AmorePacific is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of AmorePacific? | AmorePacific's last 12 months EBITDA is $424M. |
| What is AmorePacific's EBITDA margin? | AmorePacific's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of AmorePacific? | Current EBITDA multiple of AmorePacific is 12.0x. |
| What is the current FCF of AmorePacific? | AmorePacific's last 12 months FCF is $302M. |
| What is AmorePacific's FCF margin? | AmorePacific's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of AmorePacific? | Current FCF multiple of AmorePacific is 16.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.